New Directions in Immuno-oncology

Official twitter account of the New Directions in Immuno-oncology conference. See you in 2022!

[New Directions in Immuno-oncology @NewDirectionsIO]

We would like to express our gratitude for taking part in the New Directions in IO Conference 2021! We hope you enjoyed the experience - we look forward to seeing you next year! #CoLCentreIO2021 #immunotherapy

[Shahram Kordasti @KordastiL]

The role of immune response in higher risk MDS https://t.co/ryHErJjyAc

[Dr Charly Brown @Charly_JBrown]

Great fun helping organise the @NewDirectionsIO conference with @KordastiL - see you all next year! #CoLIOCentreIO2021 #Immunotherapy

[New Directions in Immuno-oncology @NewDirectionsIO]

Day 2 is starting with @MicheleMishto discussing spliced neoepitopes as novel targets in cancer! #CoLCentreIO2021

[New Directions in Immuno-oncology @NewDirectionsIO]

Day 1 of conference starts with an in-person poster session. OMG did we miss this!!

[New Directions in Immuno-oncology @NewDirectionsIO]

Jo Spencer from @KingsCollegeLon is talking about Dissecting immune compartments of colonic inflammation and cancer!

[New Directions in Immuno-oncology @NewDirectionsIO]

Hear how Kurt Schalper of Yale is using deep spatial analysis of the tumor immune to understand sensitivity and resistance to immunostimulatory anti-cancer treatments

[New Directions in Immuno-oncology @NewDirectionsIO]

Thanks to our sponsors @fluidigm @BCILifeSciences !

[New Directions in Immuno-oncology @NewDirectionsIO]

Day 1 of the conference has begun! Starting with keynote speaker Charles Drake #CoLCentreIO2021

[New Directions in Immuno-oncology @NewDirectionsIO]

Tomorrow is the day and you just cannot miss!
https://t.co/ug2zbm9JWg

[Standard BioTools @Standard_BioT]

Cell #barcoding is an important application that may be achieved by integrating #antibodies labeled with cadmium (Cd) into previously defined panels. Cell barcoding enables sample #multiplexing for #singlecell analysis in #masscytometry, leading to:

https://t.co/Z2iIo5pB6m

[Science and Innovation at Cancer Research UK @CRUKresearch]

A key goal of #EDx21 is to spark new collaborations in early detection. @CanaryCenter's Alice Fan explains why this conference offers a unique opportunity for networking.

Join over 300 researchers from across the globe who have already signed up: https://t.co/JQf6IqjP5N

[Cancer Research UK @CR_UK]

Show your support for Childhood Cancer Awareness Month by getting your gold ribbon pin badge at your local @CRUKShops! #CRUKYoungPeople #CCAM

[Standard BioTools @Standard_BioT]

The new e-commerce lab and instrument supply storefront is up and running! Need help transferring your account to the new e-commerce site?

If you have questions or need help transferring your existing Online Order Enablement account, we can support you: https://t.co/2sWuvsfWuJ

[Cancer Research UK @CR_UK]

Earlier this week the JCVI advised that people with severely weakened immune systems (including some people living with cancer) should be given a third COVID-19 vaccine dose. Read more on our rolling COVID-19 vaccine article 👇 https://t.co/iuLUpUf7v6

[Shahram Kordasti @KordastiL]

An interesting observation

[Standard BioTools @Standard_BioT]

Congratulations to Febe Van Maldegem on her recent Amsterdam UMC Fellowship award!

She currently works as a senior postdoc researcher @TheCrick and brings extensive experience using #ImagingMassCytometry to monitor the immune responses to #cancer.

https://t.co/pOgdanIFwf

[Cancer Research UK @CR_UK]

“I love running. As part of my recovery, I’ve signed up to Cancer Research UK’s Run 60 challenge, which takes place throughout September. I want to do my bit to help raise funds for life-saving research.” Join Jess and sign up to run 60 miles in September: https://t.co/mvCz3GNydq

[New Directions in Immuno-oncology @NewDirectionsIO]

Thanks for the support @fluidigm! Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate immune cell function and the tumor microenvironment with unprecedented resolution.

[Standard BioTools @Standard_BioT]

Attending New Directions in #ImmunoOncology: Therapies and Stratification?
Join us on Monday 6 September, 17:10 BST, for 'An XT perspective from the Crick’, to learn about the next evolution in affordable and automated high-dimensional #cytometry. #CyTOF
https://t.co/GXhNa2jQx6

[Standard BioTools @Standard_BioT]

Attending New Directions in #ImmunoOncology: Therapies and Stratification?
Join us on Monday 6 September, 17:10 BST, for 'An XT perspective from the Crick’, to learn about the next evolution in affordable and automated high-dimensional #cytometry. #CyTOF
https://t.co/GXhNa2jQx6